|
|
||||||||
RESEARCH REPORT |
1 Department of Oral Biology, The Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Tel Aviv 69978, Israel;
2 Department of Pediatric Hematology-Oncology, The Chaim Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv 52621, Israel;
3 Research Department, Herzog Hospital, Jerusalem, Israel; and
4 Department of Prosthodontics, Hebrew University Hadassah School of Dental Medicine, Ein Kerem, Jerusalem, Israel
* corresponding author, binderma{at}post.tau.ac.il
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: P2X4 purinoreceptor marginal gingival fibroblasts extracellular ATP alveolar bone loss osteoclasts
| INTRODUCTION |
|---|
|
|
|---|
| MATERIALS & METHODS |
|---|
|
|
|---|
Real-time RT-PCR
Total RNA was isolated from each group of pooled gingival tissues by the TRIzol method. A 100-µg quantity of total RNA was cleaned and precipitated with the use of an RNeasy Mini Kit (Qiagen, Valencia, CA, USA) to prepare the template for reverse transcription. Reverse-transcription (RT) reaction was carried out with the Omniscript kit (Qiagen). The specific primer pairs for the P2X4 gene were (786F) TATTCCGTCTTGGCACAATCG and (936R) AGGCGCCGGAAGGAATATC, and the TaqMan probe was (881T) TGCAACCTGGATAGAGCCGCCTCC. Primer sets were synthesized at the Sigma facility. After denaturation at 95°C for 15 min, the 50-µL samples were subjected to 2838 cycles of amplification, consisting of denaturation at 94°C for 1 min, annealing at 51.367°C for 1 min, and extension at 72°C at 1 min, followed by a final 10 min of extension at 72°C after completion of cycles. In each reaction, 18S rRNA was used as a reaction control. The results are presented as the mean of 2 experiments (Fig. 3
).
|
Sections were incubated with the primary antibody, rabbit anti-P2X4 (Catalog No. APR-002, Alomone Labs, Jerusalem, Israel). Sections were incubated with the primary antibody, diluted 1:100 in a medium containing 0.001% Trypsin inhibitor (Sigma soybean type IV), 0.3% Triton X-100, 0.05% Tween 20, 4% normal donkey serum (NDS) for 1 hr at room temperature, and then refrigerated overnight. Sections were rinsed in 0.02 M PBS, containing 4% NDS. Sections were incubated with biotinylated donkey anti-rabbit serum (catalog number AP182B, Chemicon USA, Temecula, CA, USA), diluted 1:400 in 0.02 M PBS, containing 0.3% Triton X-100, 0.05% Tween 20, and 4% NDS, for 1 hr at room temperature and then refrigerated overnight. Sections were rinsed in 0.02 M PBS containing 4% NDS and incubated with extravidin-peroxidase (Sigma Catalog number E2886), diluted 1:100 in 0.02 M PBS, for 45 min at room temperature. For color reaction, sections were incubated with a solution of diaminobenzidine (Sigma catalog number D5637) at a concentration of 0.0125% and containing 0.05% nickel ammonium sulfate for 10 min at room temperature and transferred to the same DAB solution, but with added hydrogen peroxide at a final concentration of 0.0015%. They were mounted on SuperFrost Plus glass slides (Menzel Glaser, Germany) and allowed to dry. They were then counterstained with the fluorescent dye DAPI (4',6-diamidino-2-phenylindole, dihydrochloride) (Molecular Probes, Eugene, OR, USA). DAPI was applied diluted in distilled, deionized water, 1:10,000, for 5 min at room temperature. It was then rinsed off with distilled, de-ionized water. After being dried thoroughly, slides were incubated in xylene and then cover-slipped in DPX. To control for specificity of staining, we processed a slide with the same protocol as above, except that the primary antibody solution also contained the antigen P2X4 (Alomone Labs, Jerusalem, Israel). The antibody concentration was 3 µg/mL, and the antigen concentration was 40 µg/mL. The primary antibody solution with the antigen was incubated for 1 hr at room temperature before application to the slide.
Treatments with Apyrase, Coomassie Blue R, Coomassie Blue G, and Suramin
Thirty rats were divided into 5 groups, each consisting of 6 rats. Each of the rats was anesthetized prior to surgery, as described previously (Yaffe et al., 1995, 2003). A flap was elevated with a special small periosteal elevator, on both sides of the mandible. Gelfoam pellets containing 10 µL of each of the drugs, namely, Apyrase, Sigma A Grade Vl (from potato lot 051k7019; 1 unit per 10 µL), Coomassie Blue R-250 (Bio Rad, Hercules, CA, USA) (104 M), Coomassie Blue G, Sigma (104 M), Suramin (104 M), and saline (10 µL) were applied. The Gelfoam pellet was applied between the alveolar bone and the mucoperiosteal flap. The rats were killed 21 days following the flap procedure. The mandibles were dissected out and fixed in 10% buffered formalin. The soft tissue was removed, and 1.5-mm-thick sections were prepared from the molar region only, in a buccal-lingual direction (45 sections from each side of the mandible) with the use of an IsoMet saw (Buehler, Lake Bluff, IL, USA). The sections represented the surgical area only.
Bone Loss Analysis
High-resolution x-ray microradiography was performed on all the sections in a mesio-distal direction, with Kodak Ektaspeed E safety film in a Faxitron cabinet x-ray system-Faxitron Series (Hewlett Packard), for 5 sec at 20 kVP. Sections from each rat were photographed on the same film, then scanned, image-processed, and analyzed for bone loss (Yaffe et al., 2003).
Statistical Analysis
The data are presented as the percentage of total sections in the treated-by-surgery or control sites for each group. Each treatment or control group was divided into 3 categories according to the classification of bone loss: no bone loss, N; moderate bone loss, V; or severe bone loss, H (Yaffe et al., 2003). The sections in each classification of bone loss category were counted as percentage of total sections. Statistical analysis with the paired Students t test was performed on each group. One-way analysis of variance confirmed a significant effect of the coronal and the apical surgeries. All results were considered significant at the 5% critical level.
| RESULTS |
|---|
|
|
|---|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
B ligand (RANKL), and an important link in the formation and activation of osteoclasts (Hoebertz et al., 2000; Buckley et al., 2002). The presence of other, both functional, P2X and P2Y receptors has been demonstrated in rats and human osteoclast cells (Dixon and Sims, 2000; Jorgensen et al., 2002; Hoebertz et al., 2003). Here, we are first to identify the P2X4 ligand-gated ion channel purinoreceptor in the membranes of marginal gingival cells at some distance from bone. The immuno-positively stained fibroblasts, aligned along the bundles of collagen fibers in the coronal approach surgery, suggest the presence of an intimate cellular communication path, from the coronal part of the root surface toward the alveolar bone. Our findings showed molecular changes as soon as 20 min after surgery. Later timepoints are now being tested for P2X4 expression. ATP, which is the extracellular ligand of P2X and P2Y receptors, is released locally from cells, due to mechanical deformation or cell damage induced by surgery, trauma, hypoxia, and ischemia (Buckley et al., 2002; Loomis et al., 2003). ATP flowing from damaged cells interacts directly with its purinoreceptors, stimulating the intracellular influx of calcium (Yu and Ferrier, 1994: Bumstock, 1997; Gallagher, 2004). We speculated that the propagation of the signal by intercellular ionic calcium, and by the flow of ATP toward the alveolar bone surface, can exert appreciable stimulatory effects on the formation and acivity of osteoclasts. The cells that ultimately resorb bone, the osteoclasts, may not be the same ones that sense the surgical insult and strain deprivation. In fact, our experiments demonstrated that local application, at the site of surgery, of Apyrase, which degrades the extracellular ATP, significantly reduced alveolar bone resorption. It has been shown that blocking the P2X receptor with the antagonist, oxidized ATP, inhibited osteoclasts formation in vitro and, therefore, that it may inhibit bone resorption (Dixon and Sims, 2000). In the present study, inhibitors of purinoreceptors, such as Coomassie Blue R and G, reduced alveolar bone loss significantly (Jiang et al., 2000).
In summary, surgical splitting of the fibers of the marginal gingiva stimulated an early up-regulation of the P2X4 receptor for extracellular ATP. We propose that the P2X4 purinoreceptor is the mechanosensor of strain deprivation in the gingival fibroblasts. It seems that controlling the level of extracellular ATP and its receptors locally, in the marginal gingival environment, will effectively reduce alveolar bone loss after periodontal surgery.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Received January 5, 2006; Last revision October 16, 2006; Accepted October 31, 2006
| REFERENCES |
|---|
|
|
|---|
Binderman I, Bahar H, Yaffe A (2002). Strain relaxation of fibroblasts in the marginal periodontium is the common trigger for alveolar bone resorption: a novel hypothesis. J Periodontol 73:12101215.[ISI][Medline]
Buckley KA, Hipskind RA, Gartland A, Bowler WB, Gallagher JA (2002). Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand. Bone 31:582590.[Medline]
Burnstock G (1997). The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36:11271139.[ISI][Medline]
Dixon SJ, Sims SM (2000). P2 purinergic receptors on osteoblasts and osteoclasts: potential targets for drug development. Drug Dev Res 49:187200.[Medline]
Gallagher JA (2004). ATP P2 receptors and regulation of bone effectors cells. J Musculoskelet Neuronal Interact 4:125127.[Medline]
Grevstad HJ (1993). Doxycycline prevents root resorption and alveolar bone loss in rats after periodontal surgery. Scand J Dent Res 101:287291.[ISI][Medline]
Hoebertz A, Townsend-Nicholson A, Glass R, Burnstock G, Arnett TR (2000). Expression of P2 receptors in bone and cultured bone cells. Bone 27:503510.[Medline]
Hoebertz A, Arnett TR, Burnstock G (2003). Regulation of bone resorption and formation by purines and pyrimidines. Trends Pharmacol Sci 24:290297.[Medline]
Jiang LH, Mackenzie AB, North RA, Surprenant A (2000). Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol 58:8288.
Jorgensen NR, Henriksen Z, Sorensen OH, Eriksen EF, Civitelli R, Steinberg TH (2002). Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors. J Biol Chem 277:75747580.
Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, et al. (2001). DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 20:22252234.[ISI][Medline]
Kaynak D, Meffert R, Gunhan M, Gunhan O, Ozkaya O (2000). A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 71:790796.[ISI][Medline]
Loomis WH, Namiki S, Ostrom RS, Insel PA, Junger WH (2003). Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and P38 MAPK activation. J Biol Chem 278:45904596.
Naemsch LN, Weidema AF, Sims SM, Underhill TM, Dixon SJ (1999). P2X4 purinoreceptors mediate an ATP-activated, non selective cation current in rabbit osteoclasts. J Cell Sci 112:44254435.[Abstract]
Yaffe A, Fine N, Alt I, Biederman I (1995). The effect of bisphosphonate on alveolar bone resorption following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 66:9991003.[ISI][Medline]
Yaffe A, Herman A, Bahar H, Biederman I (2003). Combined local application of tetracycline and bisphosphonate reduces alveolar bone resorption in rats. J Periodontol 74:10381042.[ISI][Medline]
Yu H, Ferrier J (1994). Mechanisms of ATP-induced Ca+2 signaling in osteoclasts. Cell Signal 6:905914.[ISI][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |